抗癌药 NGA-DHAQ 的趋肝性及其机理研究

  • 摘要: 利用放射性核素示踪法研究抗癌药半乳糖新糖白蛋白-米托蒽醌(NGA-DHAQ)的趋肝性及其机理,探讨其作为受体介导肝靶向抗癌药的可能性。以哺乳动物肝细胞无唾液酸糖蛋白受体的特异性配体NGA为载体,通过丁二酰胺桥与抗癌药DHAQ偶联,制备了肝靶向抗癌药NGA-DHAQ;采用99Tcm标记后,进行家兔和鸡显像、小鼠体内分布实验,并对静注NGA-DHAQ小鼠的血、肝样品进行HPLC检测。核素示踪研究表明,NGA-DHAQ有高度的趋肝性和受体介导结合特性,肝摄取峰值达65%。HPLC检测证实NGA-DHAQ在血中十分稳定,NGA能有效地将其导向肝脏,肝、血药时曲线下面积之比达66.49,验证了核素示踪研究的结果。因此,NGA-DHAQ作为受体介导肝靶向抗癌药具有进一步研究的价值。

     

    Abstract: STUDIES ON LIVERTAXIS OF ANTINEOPLASTIC AGENT NGADHAQ AND ITS MECHANISMGuan Changtian Li Lin Li Yunchun(1st University Hospital, West China University of Medical Sciences, Chengdu 610041)Chen Wen Li Tongling Pang Qijie(School of Pharmacy, West China University of Medical Sciences, Chengdu 610041)ABSTRACTThe livertaxis of antineoplastic agent galactosylneoglycoalbuminmitoxantrone(NGADHAQ) and its mechanism using radioactive tracer technique is studied. NGA is a synthetic ligand specific for asialoglycoprotein receptor, which existed in the mammalian liver only. NGA as a carrier of hepatic targeting agents is coupled with an antineoplastic agent DHAQ via a butanediamide bridge to form a coujugator. NGADHAQ is labelled with 99Tcm. The data of rabbit and chick imaging, distribution in mice and HPLC assay are obtained. The results revealed that DHAQ has remarkable livertaxis and its uptake in liver is over 65% with the feature of receptormediated binding to hepatocytes in vivo. The results show that NGADHAQ is a potential receptormediated hepatic targeting antineoplastic agent.Key words antineoplastic agents galactosyl neoglycoalbuminmitoxantrone(NGADHAQ) liver cancer pharmacology livertaxis

     

/

返回文章
返回